amifampridine
Term · Oncology and biomedicine · MLC-T-ONC-010021
An organic compound derived from pyridine with potassium channel inhibition activity. Amifampridine inhibits potassium channel efflux, increasing the duration of the action potential, which results in an increase in the duration of calcium channel opening and enhanced acetylcholine (ACh) release. Increased ACh availability at the motor end plate allows muscles to contract.
| Identifier | MLC-T-ONC-010021 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | 3,4-DAP |
| Synonyms | 3,4-pyridinediamine; 4,5-diaminopyridine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010021",
"term": "amifampridine",
"field": "Oncology and biomedicine",
"definition": "An organic compound derived from pyridine with potassium channel inhibition activity. Amifampridine inhibits potassium channel efflux, increasing the duration of the action potential, which results in an increase in the duration of calcium channel opening and enhanced acetylcholine (ACh) release. Increased ACh availability at the motor end plate allows muscles to contract.",
"abbreviation": "3,4-DAP",
"synonyms": [
"3,4-pyridinediamine",
"4,5-diaminopyridine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/amifampridine/"
}
Record 959 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.